F&V Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
F&V Capital Management's BMY Position: Q3 2026 in Review
F&V Capital Management increased its Bristol-Myers Squibb (BMY) stake by 0.65% in Q3 2026, buying an estimated $115K and bringing the position to 284,421 shares worth $17.7M. The position accounts for 3.16% of the portfolio, ranked #14.
F&V Capital Management first reported a position in BMY in Q4 2019 and has held it in 26 quarters since. 2,567 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- F&V Capital Management held 284,421 shares of Bristol-Myers Squibb worth $17.7M as of Q3 2026.
- F&V Capital Management bought 1,825 Bristol-Myers Squibb shares in Q3 2026, an estimated $115K.
- Bristol-Myers Squibb made up 3.16% of F&V Capital Management's portfolio in Q3 2026, its #14 holding.
- F&V Capital Management first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 26 quarters since.
- 2,567 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on F&V Capital Management's 13F filing for Q3 2026, filed 19 Oct 2026.